S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

SER Serina Therapeutics Inc

4.81

0.00 (0.00%)

Pre Market

Last Updated: 03:09:33

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Serina Therapeutics (AMEX:SER)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Serina Therapeutics Charts.

Serina Therapeutics (AMEX:SER)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Serina Therapeutics Charts.

Serina Therapeutics Inc News

Serina Therapeutics Announces Sale of UniverXome Subsidiary
Wednesday 15 January 2025 (6 days ago) • GlobeNewswire Inc.

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors
Tuesday 14 January 2025 (7 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 6 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 18 December 2024 (1 month ago) • Edgar (US Regulatory)

Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024
Monday 16 December 2024 (1 month ago) • GlobeNewswire Inc.

Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit
Wednesday 11 December 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Monday 9 December 2024 (1 month ago) • Edgar (US Regulatory)

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients
Monday 2 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 2 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

More Serina Therapeutics Inc News Articles

DB X-Trackers S&P 500 2x...

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions